Compositions and Methods Employing Aminopterin

Abstract

The present invention relates to pharmaceutical compositions containing the antifolate aminopterin, processes for making the compositions, and methods of using them to treat disorders in adult and pediatric patients. Pharmaceutical compositions substantially free of impurities are provided comprising a therapeutically effective amount of aminopterin, or a pharmaceutically acceptable salt thereof. Relative to the teachings of the prior art, the disclosed methods and compositions provide unexpected improvements that include a greater interpatient oral bioavailability in pediatric patients, a smaller interpatient coefficient of variation of oral bioavailability, a smaller mean intrapatient coefficient of variation of oral bioavailability, a greater therapeutic index, a smaller coefficient of variation of toxicity, efficacy in combination therapy, and efficacy of certain polyglutamated metabolites.

1 - 26 . (canceled) 
   
   
       27 . A method for treating a disorder in a patient, comprising administering to said patient a pharmaceutical composition comprising a therapeutically effective amount of aminopterin, or a pharmaceutically acceptable salt thereof, wherein the disorder is a B lineage lymphoma or a T lineage lymphoma. 
   
   
       28 . The method of  claim 27  wherein the therapeutically effective amount of aminopterin is substantially free of folic acid. 
   
   
       29 . The method of  claim 28  wherein the therapeutically effective amount of aminopterin contains less than 1% folic acid. 
   
   
       30 . A pharmaceutical composition comprising a therapeutically effective amount of aminopterin, or a pharmaceutically acceptable salt thereof, substantially free of folic acid. 
   
   
       31 . The pharmaceutical composition of  claim 30 , wherein the therapeutically effective amount of aminopterin contains less than 1% folic acid.